Mar M, Morales A, Colell A, Garca-Ruiz C, Fernndez-Checa JC
It is always advisable to assess other causes and consult a healthcare professional
Seiwerth S., Milavic M., Vukojevic J., et al
To address the challenges faced by MSC therapy for kidney diseases, more effective and safe ways of MSC delivery must be developed in order to improve the efficiency and survival rate of stem cells reaching the therapeutic target area
Protein intake and exercise for optimal muscle function with aging: recommendations from the ESPEN expert group
In a Phase 2 trial, weight loss with the CagriSema combination reached approximately 15.6%, compared with cagrilintide monotherapy at ~8.1% and semaglutide monotherapy at ~5.1%